Author of the publication

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

Daniel Kempf University of Stuttgart

GALÆXI Application: NASA Rotor 37, , , , , , , , and . Dataset, (2024)Related to: Kempf, Daniel et al. “GALÆXI: Solving complex compressible flows with high-order discontinuous Galerkin methods on accelerator-based systems.” (2024). arXiv: 2404.12703.
GALÆXI Application: NASA Rotor 37, , , , , , , , and . Dataset, (2024)Related to: Kempf, Daniel et al. “GALÆXI: Solving complex compressible flows with high-order discontinuous Galerkin methods on accelerator-based systems.” (2024). arXiv: 2404.12703.GALÆXI Validation: Taylor-Green Vortex, , , , , , , , and . Dataset, (2024)Related to: Kempf, Daniel et al. “GALÆXI: Solving complex compressible flows with high-order discontinuous Galerkin methods on accelerator-based systems.” (2024). arXiv: 2404.12703.GALÆXI Verification: Convergence Tests, , , , , , , , and . Dataset, (2024)Related to: Kempf, Daniel et al. “GALÆXI: Solving complex compressible flows with high-order discontinuous Galerkin methods on accelerator-based systems.” (2024). arXiv: 2404.12703.
 

Other publications of authors with the same name

Development of a protein signature to enable clinical positioning of IAP inhibitors in colorectal cancer, , , , , , , , and . The FEBS Journal, (March 2021)A Machine Learning Platform to Optimize the Translation of Personalized Network Models to the Clinic, , , , , , , , , and 7 other author(s). JCO Clinical Cancer Informatics, (2019)A Machine Learning Platform to Optimize the Translation of Personalized Network Models to the Clinic., , , , , , , , , and 7 other author(s). JCO clinical cancer informatics, (April 2019)Simulating and predicting cellular and in vivo responses of colon cancer to combined treatment with chemotherapy and IAP antagonist Birinapant/TL32711, , , , , , , , and . Cell death and differentiation, 25 (11): 1952-1966 (2018)An atlas of inter- and intra-tumor heterogeneity of apoptosis competency in colorectal cancer tissue at single-cell resolution, , , , , , , , , and 12 other author(s). Cell death & differentiation, 29 (4): 806-817 (2022)Exploratory multiplex tissue image analysis of the impact of heterogeneity in the microenvironment of primary colorectal cancer on apoptosis markers in patients, , , , , , , , , and 7 other author(s). Proceedings: AACR Annual Meeting 2019, 79, 13, Suppl., page LB-088. Philadelphia, Pa., AACR, (2019)Development of a protein signature to enable clinical positioning of IAP inhibitors in colorectal cancer, , , , , , , , , and . The FEBS journal, 288 (18): 5374-5388 (2021)A Stepwise Integrated Approach to Personalized Risk Predictions in Stage III Colorectal Cancer, , , , , , , , , and 20 other author(s). Clinical cancer research, 23 (5): 1200-1212 (2017)RALB GTPase : A critical regulator of DR5 cell surface expression and TRAIL sensitivity in RAS mutant colorectal cancer, , , , , , , , , and 4 other author(s). Proceedings: AACR Annual Meeting 2019, 79, 13, Suppl., page 5103. Philadelphia, Pa., AACR, (2019)RALB GTPase : a critical regulator of DR5 expression and TRAIL sensitivity in KRAS mutant colorectal cancer, , , , , , , , , and 9 other author(s). Cell death & disease, (2020)